Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Med In AS
AS
Active
Org 947788612
Lønnåskollen 42A, 1362
Hosle
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1988 · 38 years old
2 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Med In AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
2 063
2 319
2 449
2 446
2 418
Staff expenses
−832
−832
−676
−567
−565
EBITDA
311
569
806
938
937
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
311
569
806
938
937
Net financials
−336
1 019
497
−1 714
533
Profit before tax
−24
1 588
1 303
−776
1 470
Tax
22
246
296
181
346
Net profit
−47
1 342
1 007
−957
1 124
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 096
4 581
3 674
2 940
4 437
Equity
3 653
3 899
2 757
2 150
3 507
Long-term debt
0
0
0
0
0
Short-term debt
444
682
916
790
930
Total debt
444
682
916
790
930
Financial ratios
5-year trend
EBITDA margin
15,1 %
This company
15,8 %
Market median
This company
Market median
4% below market
2021
2025
Equity ratio
89,2 %
This company
38,2 %
Market median
This company
Market median
134% above market
2021
2025
Return on equity
−1,3 %
This company
18,4 %
Market median
This company
Market median
107% below market
2021
2025
Net profit margin
−2,3 %
This company
8,1 %
Market median
This company
Market median
128% below market
2021
2025
Asset turnover
0,50×
This company
1,12×
Market median
This company
Market median
55% below market
2021
2025
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Med In AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
